IVDR Compliance Focus Platomics specializes in automating regulatory processes for in vitro diagnostic products under EU IVDR, presenting a clear opportunity to upsell expanded regulatory automation, pilot expansions, and broader platform adoption with additional IVDR-supported workflows across partners and customers.

Strategic Partnerships Recent and ongoing collaborations with Pillar Biosciences, Agilent Technologies, Twist Bioscience, Biocrates, Sequentia Biotech, and others indicate a conducive path to co-sell regulatory automation as part of integrated NGS, metabolomics, and omics pipelines, suggesting joint go-to-market motions with instrument and assay vendors.

Multi-Industry Reach Customer and partner mix spans sequencing, metabolomics, and laboratory documentation needs, signaling opportunities to cross-sell across adjacent life sciences segments and expand presence with labs and manufacturers seeking compliant data workflows and audit-ready documentation.

Platform Expansion Platomics’ PlatoX platform emphasizes digitalized regulatory work powered by intelligent data; new integrations with analytics, cloud infrastructure, and lab instrumentation partners can be leveraged to offer end-to-end compliance automation bundled with data analytics and reporting capabilities.

Growth Signals With revenue in the low to mid single digits and a $16M funding base, there is readiness for sales expansion through enterprise deals, pilot programs, and co-development opportunities, especially targeting labs and manufacturers preparing for IVDR transitions and complex documentation needs.